title: Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB.
abstract: hBVR is a Ser/Thr/Tyr kinase/scaffold protein/transcription factor/intracellular transporter of regulators. hBVR is an upstream activator of the insulin/IGF-1/MAPK/PI3K signaling pathway, and of NF-kappaB. As a reductase, it converts biliverdin to the antioxidant, bilirubin. hBVR gene has 8 exons; exon 1 is not translated. We report the characterization of hBVR promoter and its negative and positive regulation, respectively, by TNF-alpha and hypoxia. The 5' end of exon 1 was defined by primer extension analyses; deletion of an inhibitor sequence 350-425 bp upstream of this exon enhanced the promoter activity. One of two NF-kappaB binding sites in the 836-bp promoter was functional; the P65 subunit of NF-kappaB and TNF-alpha acted as inhibitors. On the basis of EMSA and ChIP assays, TNF-alpha treatment increases binding of NF-kappaB to its regulatory element. Overexpression of IkappaB increased hBVR mRNA. Biliverdin, but not bilirubin, was as effective as TNF-alpha in inhibiting hBVR promoter activity. Only one of 4 hypoxia responsive elements (HREs) bound to HIF-1alpha and ARNT expressed in HEK293A cells. An abasic site was introduced at the 3' G of the HRE. This element bound HIF-1 in the gel shift and in in-cell luciferase assays. hBVR was detected in the nucleus at 1, 2, and 4 h after hypoxia (1% O(2)), at which times its kinase and reductase activities were increased. Because hypoxia positively influences hBVR promoter and phosphorylation and TNF-alpha activated NF-kappaB inhibits the promoter, while biliverdin inhibits both NF-kappaB activity and hBVR promoter, we propose a regulatory mechanism for NF-kappaB by hypoxia and TNF-alpha centered on hBVR/biliverdin.
authors.affiliation: Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642, USA.
authors.forename: Peter E M
authors.initials: PE
authors.lastname: Gibbs
authors.forename: Tihomir
authors.initials: T
authors.lastname: Miralem
authors.forename: Mahin D
authors.initials: MD
authors.lastname: Maines
mesh_terms: D002460:Cell Line; D047369:Chromatin Immunoprecipitation; D024202:Electrophoretic Mobility Shift Assay; D004789:Enzyme Activation / Q000187:drug effects; D005091:Exons / Q000235:genetics; D006801:Humans; D000860:Hypoxia / Q000235:genetics / Q000503:physiopathology*; D018613:Microscopy, Confocal; D016328:NF-kappa B / Q000378:metabolism*; D044925:Oxidoreductases Acting on CH-CH Group Donors / Q000235:genetics*; D010766:Phosphorylation; D011401:Promoter Regions, Genetic; D011485:Protein Binding / Q000235:genetics / Q000502:physiology; D050436:Regulatory Elements, Transcriptional; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D016328:NF-kappa B; D014409:Tumor Necrosis Factor-alpha; D044925:Oxidoreductases Acting on CH-CH Group Donors; C019789:biliverdin reductase
references.citation: Hepatology. 2010 Feb;51(2):398-404
references.pmid: 20044809
references.citation: Annu Rev Pharmacol Toxicol. 2010;50:323-54
references.pmid: 20055707
references.citation: Cardiovasc Res. 2004 Aug 15;63(3):545-52
references.pmid: 15276480
references.citation: Pharmacol Rep. 2008 Jan-Feb;60(1):38-48
references.pmid: 18276984
references.citation: Am J Transplant. 2005 Feb;5(2):282-91
references.pmid: 15643987
references.citation: Eur J Biochem. 1996 Jan 15;235(1-2):372-81
references.pmid: 8631357
references.citation: Mol Pharmacol. 1997 Oct;52(4):590-9
references.pmid: 9380021
references.citation: J Biol Chem. 2002 Mar 15;277(11):9226-32
references.pmid: 11773068
references.citation: J Am Soc Nephrol. 2008 Feb;19(2):380-7
references.pmid: 18184861
references.citation: Drugs Aging. 2001;18(9):685-716
references.pmid: 11599635
references.citation: Nature. 1999 May 20;399(6733):271-5
references.pmid: 10353251
references.citation: Free Radic Biol Med. 2003 Aug 15;35(4):341-50
references.pmid: 12899937
references.citation: Am J Physiol Lung Cell Mol Physiol. 2000 Jul;279(1):L175-82
references.pmid: 10893216
references.citation: J Biol Chem. 2007 Mar 16;282(11):8110-22
references.pmid: 17227757
references.citation: Nat Struct Biol. 2001 Mar;8(3):198-200
references.pmid: 11224558
references.citation: J Biol Chem. 2000 Aug 18;275(33):25733-41
references.pmid: 10823831
references.citation: Mol Cell. 2002 Oct;10(4):693-5
references.pmid: 12419209
references.citation: Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):487-94
references.pmid: 16677092
references.citation: J Biol Chem. 2005 Apr 29;280(17):17084-92
references.pmid: 15741166
references.citation: Biochem J. 2008 Aug 1;413(3):405-16
references.pmid: 18412543
references.citation: Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W217-21
references.pmid: 15215384
references.citation: J Biol Chem. 2001 Apr 6;276(14):10929-34
references.pmid: 11278740
references.citation: Proc Natl Acad Sci U S A. 2005 May 17;102(20):7109-14
references.pmid: 15870194
references.citation: Oncogene. 1999 Nov 22;18(49):6853-66
references.pmid: 10602461
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16093-8
references.pmid: 12456881
references.citation: Cancer Res. 2010 Jan 15;70(2):813-23
references.pmid: 20068160
references.citation: Trends Biochem Sci. 1992 Oct;17(10):418-22
references.pmid: 1455510
references.citation: Arch Biochem Biophys. 1989 May 1;270(2):513-20
references.pmid: 2705777
references.citation: Physiology (Bethesda). 2005 Dec;20:382-9
references.pmid: 16287987
references.citation: Nat Rev Genet. 2007 Jun;8(6):424-36
references.pmid: 17486122
references.citation: Biochem J. 2007 Jan 1;401(1):227-34
references.pmid: 16952279
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5171-6
references.pmid: 19286972
references.citation: FASEB J. 2005 Mar;19(3):387-94
references.pmid: 15746182
references.citation: J Biol Chem. 2010 Apr 23;285(17):12551-8
references.pmid: 20177069
references.citation: J Mol Biol. 2002 Jun 21;319(5):1199-210
references.pmid: 12079357
references.citation: Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):80-91
references.pmid: 15650398
references.citation: Arch Biochem Biophys. 2002 Sep 15;405(2):265-74
references.pmid: 12220541
references.citation: Gastroenterology. 2004 Aug;127(2):595-606
references.pmid: 15300591
references.citation: J Biol Chem. 1986 Jan 5;261(1):411-9
references.pmid: 3079757
references.citation: J Mol Cell Cardiol. 2007 Nov;43(5):580-92
references.pmid: 17920074
references.citation: Oncogene. 1999 Nov 1;18(45):6163-71
references.pmid: 10557108
references.citation: Mol Pharmacol. 2004 Oct;66(4):773-9
references.pmid: 15269289
references.citation: Pharmacol Rev. 2008 Mar;60(1):79-127
references.pmid: 18323402
references.citation: Free Radic Biol Med. 2007 Dec 15;43(12):1616-26
references.pmid: 18037127
references.citation: Biochem J. 2009 Aug 13;422(2):353-61
references.pmid: 19534727
references.citation: Proc Natl Acad Sci U S A. 2008 May 13;105(19):6870-5
references.pmid: 18463290
references.citation: J Biol Chem. 1994 Sep 9;269(36):22858-67
references.pmid: 8077238
references.citation: Genome Res. 2004 Mar;14(3):472-7
references.pmid: 14993211
references.citation: J Biol Chem. 2009 Oct 23;284(43):29251-9
references.pmid: 19690164
references.citation: FASEB J. 2007 Dec;21(14):3949-62
references.pmid: 17639074
references.citation: J Biol Chem. 1981 Apr 25;256(8):3956-62
references.pmid: 7217067
references.citation: Nat Struct Biol. 2001 Mar;8(3):221-5
references.pmid: 11224565
references.citation: Biochem Biophys Res Commun. 2004 Jan 30;314(1):31-8
references.pmid: 14715242
references.citation: Int J Cancer. 2007 Dec 1;121(11):2567-74
references.pmid: 17683071
references.citation: Histol Histopathol. 2006 Jun;21(6):679-85
references.pmid: 16528678
references.citation: Am J Respir Cell Mol Biol. 2007 Feb;36(2):175-82
references.pmid: 16980550
references.citation: Crit Rev Eukaryot Gene Expr. 2008;18(3):207-50
references.pmid: 18540824
references.citation: Trends Pharmacol Sci. 2009 Mar;30(3):129-37
references.pmid: 19217170
references.citation: J Biol Chem. 2009 Aug 7;284(32):21369-78
references.pmid: 19509285
references.citation: J Biol Chem. 1992 Oct 25;267(30):21894-900
references.pmid: 1400499
references.citation: Gene. 1995 Jul 28;160(2):235-40
references.pmid: 7642101
references.citation: Brain Res. 1995 Feb 20;672(1-2):29-41
references.pmid: 7749751
references.citation: J Biol Chem. 2007 Jul 13;282(28):20621-33
references.pmid: 17430897
references.citation: J Pharmacol Exp Ther. 2001 Mar;296(3):1091-7
references.pmid: 11181945
references.citation: J Urol. 1999 Oct;162(4):1467-72
references.pmid: 10492239
references.citation: EMBO J. 2001 Sep 17;20(18):5197-206
references.pmid: 11566883
references.citation: Nature. 2004 Apr 1;428(6982):493-521
references.pmid: 15057822
references.citation: J Biol Chem. 2004 May 7;279(19):19916-23
references.pmid: 14988408
references.citation: J Biol Chem. 1995 May 19;270(20):11977-84
references.pmid: 7538129
references.citation: J Bacteriol. 2005 Mar;187(6):1974-84
references.pmid: 15743945
references.citation: Mamm Genome. 2003 Oct;14(10):673-8
references.pmid: 14694903
references.citation: J Neurochem. 1993 Sep;61(3):1015-23
references.pmid: 8360669
references.citation: Biochim Biophys Acta. 2002 Oct 11;1578(1-3):73-83
references.pmid: 12393189